国际标准期刊号: 2157-2526

生物恐怖主义和生物防御杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 研究圣经
  • 中国知网(CNKI)
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Detection and Identification of a Novel Pathogen

Anderson Avon

The rapid and accurate detection and identification of novel pathogens are critical for timely public health response and effective management of infectious diseases. In this study, we present a comprehensive approach for the detection and identification of a novel pathogen, leveraging advanced molecular techniques and bioinformatics analysis. First, we employed metagenomic sequencing to capture and sequence the entire genetic material present in clinical samples collected from affected individuals. Subsequently, we utilized state-of-the-art bioinformatics tools to analyze the metagenomic data, enabling the identification and characterization of the pathogen's genome. To validate the identification, we developed specific molecular assays, including polymerase chain reaction (PCR) and nextgeneration sequencing (NGS), targeting unique genetic markers of the novel pathogen. These assays were evaluated using a panel of known pathogens and clinical samples from patients with confirmed infections. Furthermore, we conducted a comprehensive phylogenetic analysis to assess the evolutionary relationship of the novel pathogen with other related species, shedding light on its potential origin and transmission dynamics. The detection and identification pipeline developed in this study demonstrated high sensitivity and specificity, accurately detecting and characterizing the novel pathogen from diverse clinical samples. Overall, this research provides a robust framework for the timely identification and characterization of emerging pathogens, facilitating rapid public health response and guiding appropriate interventions to mitigate the spread and impact of infectious diseases.